ClinicalTrials.gov
public full text
Public Domain
Comparing Efficacy and Safety of TJO-083 in Dry Eye Diseases Patients
In patients with dry eye syndrome, the test drug(TJO-083) or the control drug is administered for 12 weeks, and the corneal staining of each group would be evaluated. The purpose of this clinical Study is to demonstrate that the test drug is not clinically inferior to the control drug.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- TRYPTYR as a Treatment for Patients With Dry Eye Disease (DED)#1085518
- Efficacy and Safety of USL for Dry Eye Disease#1113233
- Efficacy of Lipid-containing Artificial Tears in the Treatment of Dry Eye#885690
- The RENEW Trial: A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Adaptive Phase 3 Clinical Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease#837742
- Management of Dry Eye Disease After Cataract Surgery With Topical Hyaluronic Acid and Gingko Biloba#1093752
Record · ID 1139666
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive